Related Articles
VASOACTIVE-INTESTINAL-PEPTIDE (VIP) MODULATES THE GROWTH FRACTION OF EPITHELIAL SKIN CELLS
VASOACTIVE-INTESTINAL-PEPTIDE (VIP) MODULATES EARLY EVENTS OF MIGRATION IN HUMAN KERATINOCYTES
Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone
Inhibition of signal transduction in EGF-dependent epithelial cell lines
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: Antagonistic action of a growth-hormone-releasing hormone analog